↓ Skip to main content

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

Overview of attention for article published in The Lancet Gastroenterology & Hepatology, June 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 1,651)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
90 news outlets
blogs
2 blogs
twitter
32 X users
facebook
2 Facebook pages
reddit
1 Redditor

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
Published in
The Lancet Gastroenterology & Hepatology, June 2023
DOI 10.1016/s2468-1253(23)00145-0
Pubmed ID
Authors

Kara L Kliewer, Cristin Murray-Petzold, Margaret H Collins, Juan P Abonia, Scott M Bolton, Lauren A DiTommaso, Lisa J Martin, Xue Zhang, Vincent A Mukkada, Philip E Putnam, Erinn S Kellner, Ashley L Devonshire, Justin T Schwartz, Vidhya A Kunnathur, Chen E Rosenberg, John L Lyles, Tetsuo Shoda, Amy D Klion, Marc E Rothenberg

X Demographics

X Demographics

The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 8%
Student > Master 2 8%
Student > Doctoral Student 1 4%
Other 1 4%
Student > Ph. D. Student 1 4%
Other 1 4%
Unknown 16 67%
Readers by discipline Count As %
Medicine and Dentistry 3 13%
Unspecified 2 8%
Agricultural and Biological Sciences 1 4%
Nursing and Health Professions 1 4%
Unknown 17 71%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 686. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2023.
All research outputs
#30,489
of 25,408,670 outputs
Outputs from The Lancet Gastroenterology & Hepatology
#8
of 1,651 outputs
Outputs of similar age
#803
of 371,397 outputs
Outputs of similar age from The Lancet Gastroenterology & Hepatology
#2
of 58 outputs
Altmetric has tracked 25,408,670 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,651 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,397 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.